VEGFA and neoplasm: Apart from its angiogenic roles, VEGF also mediates immunosuppression in the TME by driving tumor-associated immunosuppression factors, such as inducing vascular abnormalities, reducing tumor antigen presentation, inhibiting the proliferation and cytotoxic function of effector T cells, and increasing Tregs and myeloid-derived suppressor cells (MDSCs) (44).